0001562180-20-004697.txt : 20200625
0001562180-20-004697.hdr.sgml : 20200625
20200625214946
ACCESSION NUMBER: 0001562180-20-004697
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200623
FILED AS OF DATE: 20200625
DATE AS OF CHANGE: 20200625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berman Robert
CENTRAL INDEX KEY: 0001704483
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 20991014
MAIL ADDRESS:
STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP
STREET 2: 234 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-06-23
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001704483
Berman Robert
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
false
true
false
false
Special Projects & Med Ovrsght
Common Shares
2020-06-23
4
M
false
4296.00
0.61
A
4637.00
D
Common Shares
2020-06-23
4
S
false
4296.00
75.0538
D
341.00
D
Common Shares
550000.00
I
By Berman Family Trust 2013
Common Shares
240500.00
I
By Berman Marital Trust 2013
Common Shares
50.00
I
Owned by Spouse
Employee Stock Option (right to buy)
0.61
2020-06-23
4
M
false
4296.00
0.00
D
2024-11-25
Common Shares
4296.00
58404.00
D
These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 - $75.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
The option, representing a right to purchase a total of 225,000 shares, was granted on November 26, 2014, and vested in four equal installments on November 26, 2014, 2015, 2016 and 2017
/s/ Jim Engelhart, Attorney-in-Fact
2020-06-25